Hansoh Pharmaceutical Group Company Limited
HNSPF
$5.20
$0.4910.40%
OTC PK
| 12/31/2024 | 09/30/2024 | 06/30/2024 | 03/31/2024 | 12/31/2023 | |
|---|---|---|---|---|---|
| Net Income | -16.91% | -16.24% | 104.63% | 101.53% | 52.22% |
| Total Depreciation and Amortization | 2.08% | 2.89% | 13.45% | 11.74% | -4.19% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -52.09% | -53.31% | 6.36% | 7.78% | -437.23% |
| Change in Net Operating Assets | -192.37% | -193.11% | 41.93% | 39.79% | 123.25% |
| Cash from Operations | -39.89% | -39.41% | 126.46% | 123.03% | 100.45% |
| Capital Expenditure | 5.04% | 4.28% | -6.38% | -4.77% | -43.77% |
| Sale of Property, Plant, and Equipment | -41.07% | -40.60% | 668.75% | 657.18% | -51.88% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -2,531.70% | -2,551.11% | 109.56% | 106.39% | 137.27% |
| Cash from Investing | -11,859.18% | -11,952.85% | 120.01% | 116.68% | 106.77% |
| Total Debt Issued | -100.00% | -100.00% | -- | -- | -- |
| Total Debt Repaid | 98.76% | 98.76% | -52,086.55% | -52,086.55% | -2,498.58% |
| Issuance of Common Stock | -- | -- | -12.64% | -12.64% | -100.00% |
| Repurchase of Common Stock | 100.00% | 100.00% | 57.59% | 57.59% | -90.81% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -186.05% | -188.33% | -- | -- | 9.89% |
| Other Financing Activities | 100.00% | 100.00% | -- | -- | -- |
| Cash from Financing | -166.85% | -168.98% | -7,947.22% | -7,825.44% | 9.33% |
| Foreign Exchange rate Adjustments | 53.42% | 53.05% | 47.55% | 48.34% | -122.23% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | -459.45% | -462.32% | -61.78% | -62.36% | 3,069.92% |